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httpIntroduction: A 55 year old man who suffered from recurrent traumatic multi-organ bleeding presented with
deterioration in kidney function and pulmonary embolism caused by a newly diagnosed renal vein thrombosis
during hospitalisation.
Report: Complete clot removal was performed successfully by catheter directed aspiration. Thrombotic emboli
were captured in a temporary filter device. A post-interventional computed tomography scan showed full
restoration of the occluded renal vein.
Discussion: Use of a temporary catheter based vena cava filter (Capturex) during catheter directed
thrombectomy is safe and should be considered to prevent thrombo-embolism in selected cases when any
rheolytic therapy is contraindicated.
 2020 The Author(s). Published by Elsevier Ltd on behalf of European Society for Vascular Surgery. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Renal vein thrombosis (RVT) is a pathology often diagnosed
in patients with nephrotic syndrome caused by anti-
thrombin deficiency.1 Other causes include blunt trauma,
tumour, venous outflow obstruction, and post kidney
transplantation. Early anticoagulation is the standard
approach to prevent thrombosis progression and pulmo-
nary embolism (PE), and may be sufficient in asymptomatic
patients with preserved normal kidney function. However,
for patients with deterioration of kidney function, treat-
ment of the RVT should be considered.1 Local thrombolysis
with or without catheter directed mechanical thrombec-
tomy (CDT) has been proposed for selected cases with
RVT.1,2 Additional temporary catheter based filter place-
ment in the vena cava inferior (IVC), such as the Capturex,
offers potential for protection from possible thrombo-
embolism during CDT. This is the report of successful uni-
lateral RVT treatment by CDT and thrombus capture using a
catheter based temporary filter in a patient with contrain-
dication for rheolytic therapy.rresponding author. Division of Angiology, Swiss Cardiovascular
, University Hospital Bern, 3010, Bern, Switzerland.
il address: axel.haine@gefaesszentrum-bern.ch (Axel Haine).
-688X/ 2020 The Author(s). Published by Elsevier Ltd on behalf of
an Society for Vascular Surgery.This is an open access article under the
NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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A 55 year old sportsman presented with a traumatic grade
IV lesion of both his spleen and left kidney as a result of a
fall when mountain biking. Endovascular treatment was
performed with selective coil embolisation. On day 7 after
this intervention the patient presented with haemodynamic
instability, and a second computed tomography (CT) scan
showed recurrent splenic bleeding. The CT was discussed
between surgeons and interventional angiologists, with
agreement for urgent coil embolisation. At that time, CT
scan newly demonstrated an obstructive left RVT and uni-
lateral distal PE (Fig. 1). Lower extremity deep vein
thrombosis (DVT) was ruled out by compression ultrasound.
Kidney function had deteriorated and showed a 40% in-
crease of serum creatinine level (130 mmol/L, estimated
glomerular filtration rate [eGFR] 57 mL/min) while respira-
tory function was preserved. Initial transient hypotensive
renal perfusion pressure, partial ischaemic renal damage as
a result of coil embolisation, and contrast media exposure
were discussed as possible causes of the acute kidney
injury. Multidisciplinary discussion on treatment options
concluded that renal vein CDT should be performed
(AngioJet, Solent Omni, Boston Scientific, Marlborough, MA,
USA), in combination with a catheter based filter in the
suprarenal segment of the IVC.
First, the right common femoral vein was punctured
under ultrasound guidance and a 6F 10 cm sheath (Glide-
sheath Slender, Terumo, Tokyo, Japan) was inserted. The left
Figure 1. Computed tomography scan on day 7 showing (A) left renal vein thrombus (arrow) and (B) right lobe peripheral pulmonary
embolism (arrow).
Filter Usage for Catheter Directed Thrombectomy 17renal vein was selectively catheterised with a 5F shepherd
hook shaped catheter (Beacon, Cook, Bloomington, IN, USA)
and a venogram was performed (Fig. 2A). Second, the ju-
gular vein was punctured and a 10F 10 cm sheath (Avanti,
Cordis, Miami, FL, USA) was inserted. The catheter based
filter (Capturex, Straub Medical, Wangs, Switzerland) was
placed in the IVC and the filter’s distal end opened at the
level of the renal vein ostium shaped like a funnel (Figs. 2B
and 3). Third, repeated 100 second runs of mechanically
assisted CDT (AngioJet, Solent Omni 6F, Boston Scientific) in
the left renal vein without rheolytic medication were per-
formed. The final venogram showed subtotal thrombus
elimination (Fig. 2C). Lastly, the filter basket containing the
thrombotic material was retrieved (Fig. 3). Ultrasound im-
aging on the following day demonstrated preserved flow in
the renal vein without detection of obstructive clots. Anti-
coagulation with unfractionated heparin in a prophylactic
dose of 10 000 units per 24 hours was started one day after
thrombus removal and absent signs of organ bleeding. This
regimen was changed on day 9 after thrombus removal to
subcutaneously administered Clexane (enoxaparin, Sanofi,
Paris, France) for treatment of the underlying PE. SerumFigure 2. (A) Venogram of the selectively catheterised left renal vein p
filter catheter in the inferior vena cava (arrow) with the need to retract
embolisation (stars) (C) Venogram after catheter directed thrombus re
(arrow).creatinine level dropped to 95 mmol/L within 48 hours post
CDT and renal function was restored completely based on
laboratory assessment one month later (eGFR >90 mL/
min). A contemporaneous final CT scan showed both
absence of residual thrombosis in the left renal vein and
preserved arterial perfusion of the renal parenchyma
(Fig. 4A and B).
This report was prepared following the principles of the
Declaration of Helsinki and approved for publishing by the
study institution. Ethical approval was obtained as well as
written informed consent and consent to publish.DISCUSSION
Therapeutic anticoagulation is the standard approach for
RVT.1 CDT with or without thrombolysis is suggested to be a
safe and efficient minimally invasive procedure in various
settings.2e4 The choice of manual thrombus aspiration or
any specific device for CDT should be guided by local
expertise because of missing high level evidence from
randomised trials. This technique has been suggested as a
first line treatment approach, especially in patients with
deteriorating kidney function, and to prevent thrombusrior to thrombus removal (B) Fluoroscopy after deployment of the
the filter 1 cm prior to treatment, and coils placed for initial arterial
moval with minor residual thrombus and restored venous outflow
Figure 3. Photograph of the catheter based vena cava filter
(Capturex), with an elongated thrombus and smaller emboli
captured inside.
Figure 4. Computed tomography scan six weeks after left renal
vein thrombus removal showing (A) no residual thrombus in the
vein (arrow) and (B) residual arterial parenchymal perfusion.
18 Axel Haine et al.progression and consecutive PE.4 When considering PE
during catheter assisted DVT treatment, this treatment
option appears to be safe for the overall population that has
been studied; however, available data differ significantly
between studies as a result of the methods used for the
diagnosis of PE. A contemporary meta-analysis by Wang
et al. found a pooled PE rate of 3.8% (95% CI 2.5e6.7),
limited to cases with known non-use of an IVC filter.5 The
PEARL registry prospectively studied the efficacy of CDT
with the AngioJet catheter, in which only one symptomatic
PE was detected by CT scan.6 In contrast, a rate of 15.6% for
symptomatic PE was reported from a recent retrospective
analysis.7 There was no difference observed for either CDT
or local catheter lysis. As the majority of these analyses
focused on symptomatic PE, the overall thrombo-embolic
burden including asymptomatic PE may be under-
estimated. Use of IVC filters to prevent PE is mostly per-
formed by leaving the filters in the IVC, likely to be
responsible for the majority of device associated compli-
cations as well as requiring potentially complicated
retrieval. However, registry data on efficacy and safety of a
catheter based filter in patients with DVT are promising in
terms of increasing patient safety with regard to PE pro-
tection and minor complications.8
In the present case, an attempt was made to prevent
thrombosis progression, to lower risk of PE, and to restore
renal venous outflow to preserve kidney function. An
additional risk of a secondary PE was considered associated
with CDT manoeuvre. As rheolytic medication was withheld
because of recurrent life threatening organ bleeding the
same day, the decision was taken for safe thrombus
extraction.
Surgical splenectomy with or without placement of a
temporary suprarenal vena cava filter with subsequent
initiation of anticoagulation may serve as an alternative
treatment approach, which could be considered on an in-
dividual basis.9
In selective clinical situations, that is where rheolytic
therapy is withheld despite a need for thrombus removal,
or in the presence of a persistent patent foramen ovale with
known risk of arterial thrombo-embolism,10 the combined
use of IVC during CDT is strongly recommended. A catheter
based cava filter, for example Capturex, seems to have ad-
vantages over a standard retrievable IVC filter in terms of its
narrow meshed design and complications associated with
the device and its easy retrieval.
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